NetworkNewsBreaks

TuesdayMar 14, 2017 9:22 am

NetworkNewsBreaks – GreeneStone Healthcare Corp. (GRST) Announces Engagement of NetworkNewsWire

Healthcare services company GreeneStone Healthcare Corp. (OTCQB: GRST) this morning announced its engagement of NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging an investor-based distribution network that includes more than 5,000 key syndication outlets, various newsletters, numerous social media channels, blogs, and other outreach tools, NNW will look to generate greater brand awareness for GreeneStone as it works to expand its presence in the U.S. treatment market through its newly-acquired facility in Delray Beach, Florida. “We are pleased to partner…

Continue Reading

MondayMar 13, 2017 1:45 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on March 13, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: HDYN 55.66% – News: Enters tri-party protocol with the Government of the Republic of Guinea and South Atlantic Petroleum HEMA 23.58% – News: Posts 2016 financial results INNL 20.64% – News: Law firm initiates class action lawsuit PRTX 18.75% – News: Granted several key patents for PRTX-100 in the United States, Europe, Canada and Japan HEWA 15.91% – News: Posts Q4, FY 2016 results AEMD 14.97% – News: Completes FDA-approved safety study of the…

Continue Reading

MondayMar 13, 2017 1:45 pm

NetworkNewsBreaks – Bridgeline Digital, Inc. (NASDAQ: BLIN) Adds Intranet Services to Engagement with National Shipping and Business Franchise Customer

Bridgeline Digital, Inc. (NASDAQ: BLIN) announced today that one of the nation’s largest franchise systems of retail shipping, postal, print and business service centers has launched a new corporate intranet powered by Bridgeline Digital’s enterprise solutions. The company currently powers the customer’s public facing website. This engagement includes a 3-year SaaS license with the total value of license and services estimated at over $500,000. The intranet further delivers for the distribution of training materials, front end user management and single sign-on for employees and franchisees, as well as a dynamic activity stream, real time connect, and the ability to define…

Continue Reading

MondayMar 13, 2017 12:21 pm

NetworkNewsBreaks – BlackStar Enterprise Group, Inc. (BEGI) Announces Engagement of NetworkNewsWire

Merchant banking and finance company BlackStar Enterprise Group, Inc. (OTC: BEGI) this morning announced its engagement of NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging an investor-based distribution network that includes more than 5,000 key syndication outlets, various newsletters, numerous social media channels, blogs, and other outreach tools, NNW will look to generate greater brand awareness for BlackStar as it continues to offer investment and financing services to early stage companies exhibiting the potential for sustained growth. “We are a…

Continue Reading

MondayMar 13, 2017 11:34 am

NetworkNewsBreaks – ProBility Media Corp. (PBYA) Announces Engagement of NetworkNewsWire

Education technology company ProBility Media Corp. (OTCQB: PBYA) this morning announced its engagement of NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging an investor-based distribution network that includes more than 5,000 key syndication outlets, various newsletters, numerous social media channels, blogs, and other outreach tools, NNW will look to generate greater brand awareness for ProBility Media as the company seeks to expand its presence in the sizable education technology market. “As a leading innovator in the EdTech space, we operate…

Continue Reading

MondayMar 13, 2017 10:44 am

NetworkNewsBreaks – Heat Biologics’ (NASDAQ: HTBX) Lung Cancer Trial Achieves Efficacy Endpoint, Advances to Phase 2; Shares Surge

Heat Biologics (NASDAQ: HTBX) is continuing a pre-market rally, currently up 20% following the company’s announcement that its phase 1b trial evaluating HS-110 in combination with Bristol-Myers Squibb’s (NYSE: BMY) nivolumab (Opdivo®) for the treatment of non-small cell lung cancer (NSCLC) has achieved the efficacy endpoint. Additionally, 5 out of 15 patients treated with the HS-110/nivolumab combination had 20% or greater tumor reduction. Upon review, the Data Monitoring Committee (DMC) determined that the positive safety profile, mechanistic evidence and encouraging signs of synergistic efficacy warranted expansion to a phase 2 trial. “We designed this trial with the Bristol-Myers Squibb Checkmate…

Continue Reading

MondayMar 13, 2017 10:41 am

NetworkNewsBreaks – ParkerVision, Inc. (NASDAQ: PRKR) Shares Sink on Motion to Terminate ITC Investigation

Shares of ParkerVision (NASDAQ: PRKR) are down 17% following the company’s early announcement that it is filing a motion to terminate its International Trade Commission (ITC) investigation in light of a recent ruling by the Administrative Law Judge (ALJ) disallowing key factual evidence in the company’s proceedings. The company was informed of this confidential ruling just prior to the start of the ITC hearing, which is scheduled to begin today. ParkerVision stated that it remains prepared to try its case based on evidence obtained in the investigation, however, the recent ruling excluding material portions of the company’s evidence resulted in…

Continue Reading

FridayMar 10, 2017 3:43 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on March 10, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: SMLR 4.68% – News: Posts Q4, FY 2016 results IPWR 6.57% – News: Presenting at the 29th Annual ROTH Conference on March 15 FCSC 4.85% – News: Announces 1-for-3 reverse stock split of its common stock LLEX 4.55% – News: Uplisting to Nasdaq Capital Market AREX 4.52% – News: Class action law firm announces investigation BPTH 4.16% – News: Presenting data at the 2017 AACR Annual Meeting April 5 SNGX 4.09% – News: Presenting…

Continue Reading

FridayMar 10, 2017 11:09 am

NetworkNewsBreaks – MySize, Inc. (NASDAQ: MYSZ) Developing New Measurement App to Support “Off-Line” Shopping

MySize (NASDAQ: MYSZ) this morning said it has started the development of a new application intended to support “off-line” shopping. The developer of proprietary smartphone measurement applications is developing the new application, which has yet to be branded, to support on site retail sales. The new application would be used by sales people in physical stores to create a measurement profile for the customer that they can then use for future purchases, both on- and off-line. This is likely to encourage return visits and increase customer loyalty and retention. "To date, it's been all about the online clothes shopping, which…

Continue Reading

FridayMar 10, 2017 11:06 am

NetworkNewsBreaks – Endocyte, Inc. (NASDAQ: ECYT) Partners with Seattle Children’s Research Institute to Develop Endocyte’s SMDC Bi-Specific Adaptors for CAR T-cell Therapies

Shares of Endocyte (NASDAQ: ECYT) are up 10% following the company’s early announcement of its collaboration with Seattle Children’s Research Institute and Dr. Michael Jensen. The partnership will develop Endocyte’s SMDC platform in the chimeric antigen receptor T-cell (CAR T-cell) immunotherapy setting through the use of Endocyte’s proprietary SMDC bi-specific adaptor molecules. The goal of the research collaboration is to move these potentially enabling technologies more quickly to patients in the clinic. “This partnership brings together Dr. Jensen’s expertise in the discovery and development of CAR T-cell therapies and Endocyte’s SMDC platform, with the aim of improving the efficacy and…

Continue Reading